Lova Sun, Barbara Burtness, Yael Flamand, Laila A. Gharzai, Mei Tang, Nabil F. Saba. "EA3231: A randomized phase III study of BRAF-targeted therapy vs cabozantinib in RAI-refractory differentiated thyroid cancer with
                    <i>BRAF</i>
                    V600Em.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps6140